A training for assessors is being conducted at the WHO Academy in Lyon from 21 to 24 April 2026 to strengthen capacity for the WHO prequalification of in vitro diagnostics (IVDs).

The cobas® MTB test by Roche Diagnostics has been added to the WHO Prequalification list, supporting access to quality‑assured molecular tuberculosis diagnostics.

WHO will hold a Prequalification Workshop for manufacturers of in vitro diagnostics (IVDs) from 8–10 June 2026 at WHO headquarters in Geneva.

The World Health Organization Prequalification Teams - Medicines Assessment and Inspections - will be attending the Shanghai SNIEC CPhi on 16-18 June 2026, in Shanghai, China.

Between 1 March and 16 April 2026, several WHO Public Assessment Reports (WHOPARs) were updated to reflect changes in product l

The WHO Prequalification Unit is expanding its scope and is establishing a roster of consultants to s

WHO Prequalification has listed three malaria rapid diagnostic tests: 

• BIOCREDIT Malaria Ag Pf (pLDH)

In 2026 more frequent dossier assessment sessions have been planned to facilitate timely review of IVD product dossiers and corrective

Lamivudine manufactured by Arene Life Sciences Private Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.